-transparent.png){kind=logo}
Administration of medroxyprogesterone acetate IP in advanced cancer with peritoneal metastases and ascitic effusion generates considerably higher drug plasma levels than those observed after PO or IM treatment. Comparison of areas under the time-concentration curves (AUC) with reference to the three administration routes indicates that after oral administration only 0.2%-17.4% (mean 5.7%; SD 3.77; 40 patients) of the administered dose is absorbed; after IM treatment a daily absorption of 0.7%-7.7% (mean 2.5%; SD 1.66; 30 patients) of the administered dose per injection site was computed.
Related Publications
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
September 1982,
Cancer treatment reports,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
June 1984,
Australian and New Zealand journal of medicine,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
April 1989,
Hinyokika kiyo. Acta urologica Japonica,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
January 1986,
Breast cancer research and treatment,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
January 1995,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
December 1987,
Cancer treatment reports,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
December 1986,
European journal of cancer & clinical oncology,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
December 1985,
The Southeast Asian journal of tropical medicine and public health,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
October 1979,
Tumori,
C M Camaggi, and
E Strocchi, and
B Costanti, and
P Beghelli, and
P Ferrari, and
F Pannuti
December 1987,
European journal of cancer & clinical oncology,
